'The ongoing class action lawsuit against several makers of testosterone medications hasn’t been going well for AbbVie—it has lost two cases so far—but the legal saga is playing out quite differently for Endo. On Thursday, a federal jury ruled that Endo’s unit Auxilium, which markets the testosterone replacement gel Testim, bears no liability in a case brought by a Tennessee man who alleges he suffered a heart attack after taking the drug." Read more at:
No comments:
Post a Comment